NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced a new contract w
So-called “bull traps” often frustrate traders, as they did on Wednesday, snaring shares of SIGA Technologies Inc SIGA — and there may be another one today.
SIGA Technologies focuses on antiviral treatments, with its lead product TPOXX (tecovirimat) approved for smallpox and other orthopoxviruses. The PALM 007 study of tecovirimat in monkeypox patients fa
NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) today announced topline results from a preliminary a
SIGA Technologies, Inc. (NASDAQ:SIGA ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Diem Nguyen - Chief Executive Officer Daniel Luckshire - Chief Financial Officer
NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conferenc
Siga Technologies Inc. (SIGA) reachead $9.72 at the closing of the latest trading day, reflecting a +0.83% change compared to its last close.
In the closing of the recent trading day, Siga Technologies Inc. (SIGA) stood at $9.06, denoting a +0.55% change from the preceding trading day.
Siga Technologies Inc. (SIGA) closed at $8.69 in the latest trading session, marking a +1.88% move from the prior day.
Siga Technologies Inc. (SIGA) reachead $7.88 at the closing of the latest trading day, reflecting a +1.81% change compared to its last close.
Further Advances SIGA's Strategy to Expand Access to TPOXX into More International Markets Further Advances SIGA's Strategy to Expand Access to TPOXX into More International Markets
SAN DIEGO--(BUSINESS WIRE)---- $CLDI #immunotherapy--Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors.

New Strong Buy Stocks for May 17th

07:31am, Friday, 17'th May 2024
CLS, DXPE, FBP, RCMT and SIGA have been added to the Zacks Rank #1 (Strong Buy) List on May 17, 2024.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
SIGA Technologies, Inc. (NASDAQ:SIGA ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Diem Nguyen - Chief Executive Officer Dan Luckshire - Chief Financial Officer Confer
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE